###begin article-title 0
###xml 105 113 105 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 54 59 <span type="species:ncbi:9606">human</span>
Minimum length requirement of the alignment domain of human telomerase RNA to sustain catalytic activity in vitro
###end article-title 0
###begin p 1
###xml 95 112 95 112 <email xmlns:xlink="http://www.w3.org/1999/xlink">sb10031@cam.ac.uk</email>
To whom correspondence should be addressed. Tel: +44 1223 336347; Fax: +44 1223 336913; Email: sb10031@cam.ac.uk
###end p 1
###begin p 2
###xml 314 319 314 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CAAUC</italic>
###xml 603 611 603 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 253 258 <span type="species:ncbi:9606">human</span>
###xml 483 488 <span type="species:ncbi:9606">human</span>
Telomeres are essential for genomic stability and cell viability. Telomerase, the enzyme responsible for telomere maintenance, is composed of a reverse transcriptase protein subunit and an integral RNA component which contains the templating domain. In human telomerase, the template region consists of 11 nt (3'-rCAAUCCCAAUC-5') and comprises an alignment domain (italicised) plus a template sequence encoding the telomeric repeat d(GGT TAG). In this study, the alignment domain of human telomerase was systematically reduced from the 3' end and the resultant recombinant enzyme activity was evaluated in vitro. Deletion or substitution of one or two residues from the 3' end of the alignment domain caused only a slight reduction in overall catalytic activity and did not alter the processivity of the enzyme. Deletion or substitution of three or more residues from the 3' end of the alignment domain resulted in total loss of catalytic activity. These results suggest that the two most 3' terminal RNA residues are relevant but not essential for overall activity and that the minimal length requirement of the alignment domain is 3 nt. Furthermore, base pairing between the 3' end of the primer substrate and the first two residues of the alignment domain is also not an absolute requirement for processive synthesis.
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin p 4
###xml 62 63 62 63 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c1">1</xref>
###xml 64 65 64 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c2">2</xref>
###xml 136 137 136 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c3">3</xref>
###xml 138 139 138 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c4">4</xref>
###xml 262 263 262 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c1">1</xref>
###xml 471 472 471 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c5">5</xref>
###xml 473 474 473 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c6">6</xref>
###xml 550 551 550 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c7">7</xref>
###xml 552 553 552 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c8">8</xref>
###xml 800 801 800 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c9">9</xref>
###xml 802 804 802 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c11">11</xref>
Telomeres are found at the termini of eukaryotic chromosomes (1,2) and consist of dGT-rich DNA sequences and their associated proteins (3,4). Telomerase is the cellular reverse transcriptase responsible for the synthesis and maintenance of the chromosomal ends (1). Telomerase compensates for the loss of telomeric DNA that occurs through incomplete replication, thereby protecting the chromosome ends against recombination, chromosome fusion or exonuclease degradation (5,6). Telomerase has also been implicated in the control of cellular lifespan (7,8). In particular, a number of studies have indicated that telomerase expression is associated with cell immortalisation and tumourigenesis, highlighting the enzyme as a potentially promising target for the development of anti-cancer therapeutics (9-11).
###end p 4
###begin p 5
###xml 166 174 166 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Euplotes</italic>
###xml 176 178 176 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c12">12</xref>
###xml 181 205 181 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 207 209 207 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c13">13</xref>
###xml 212 237 212 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Schizosaccharomyces pombe</italic>
###xml 239 241 239 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c14">14</xref>
###xml 254 256 254 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c14">14</xref>
###xml 401 412 401 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tetrahymena</italic>
###xml 426 428 426 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c15">15</xref>
###xml 429 431 429 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c17">17</xref>
###xml 587 589 587 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c15">15</xref>
###xml 590 592 590 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c16">16</xref>
###xml 181 205 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
###xml 212 237 <span type="species:ncbi:4896">Schizosaccharomyces pombe</span>
###xml 247 252 <span type="species:ncbi:9606">human</span>
Telomerase is a ribonucleoprotein minimally composed of an RNA component (TR) and a catalytic subunit (TERT), which has been identified as a reverse transcriptase in Euplotes (12), Saccharomyces cerevisiae (13), Schizosaccharomyces pombe (14) and human (14). Using biochemical and genetic tools, several telomerase-associated proteins have also been identified to be part of the holoenzyme complex in Tetrahymena and mammals (15-17). Their function remains to be unambiguously determined, but various studies indicate they may participate in telomerase assembly, function or regulation (15,16).
###end p 5
###begin p 6
###xml 72 80 72 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 206 207 206 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c1">1</xref>
###xml 208 210 208 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c18">18</xref>
###xml 211 213 211 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c19">19</xref>
###xml 297 299 297 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c20">20</xref>
###xml 358 359 358 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf575f1">1</xref>
###xml 362 364 362 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c21">21</xref>
###xml 617 619 617 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c18">18</xref>
###xml 620 622 620 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c22">22</xref>
###xml 726 727 726 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf575f1">1</xref>
###xml 758 759 758 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf575f1">1</xref>
###xml 763 765 763 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c20">20</xref>
###xml 1095 1096 1095 1096 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf575f1">1</xref>
###xml 1508 1510 1508 1510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c23">23</xref>
###xml 1511 1513 1511 1513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c25">25</xref>
###xml 1550 1551 1550 1551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf575f1">1</xref>
###xml 1796 1797 1796 1797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf575f1">1</xref>
###xml 132 138 <span type="species:ncbi:4932">yeasts</span>
###xml 143 148 <span type="species:ncbi:9606">human</span>
Telomerase elongation and substrate specificity have been characterised in vitro for a wide range of organisms, including protozoa, yeasts and human, by use of a single-stranded DNA primer extension assay (1,18,19). The likely mechanism for telomerase, first proposed by Blackburn and co-workers (20), is distinct from other classes of DNA polymerases (Fig. 1) (21). Telomerase uses a small region of its integral RNA component, called the template domain, to direct the synthesis of the dGT-rich strand of the telomeres whilst reverse transcription is mediated by the catalytic protein subunit of telomerase (TERT) (18,22). The proposed mechanism involves several defined events which include a primer recognition step (Fig. 1B) and an extension step (Fig. 1C) (20). A distinct feature of telomerase is the ability to reiteratively add telomeric repeats to a DNA primer without dissociation of enzyme and substrate. According to the current model, processive repeat addition requires the newly synthesised 3' end of the primer to re-align on the RNA template after each round of addition (Fig. 1D). Studies on telomerase from different species strongly suggest that telomerase can interact with oligonucleotide primers in a bipartite manner. It has been proposed that the 3' end of the DNA primer is aligned by hybridisation with the RNA template, whilst the 5' region of the primer is bound to a second site (the anchor site) which contributes to high affinity substrate binding and processive elongation (23-25). Following a repeat addition (Fig. 1C), the 5' region of the primer remains bound to the anchor site allowing the newly synthesised 3' end of the DNA to translocate back to the beginning of the template, without dissociation from the enzyme, for additional repeat synthe sis (Fig. 1D). Alternatively, if both sites are released simultaneously the DNA substrate dissociates from the enzyme with termination of synthesis.
###end p 6
###begin p 7
###xml 135 137 135 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c26">26</xref>
###xml 353 355 353 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c26">26</xref>
###xml 516 518 516 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UC</italic>
###xml 534 535 534 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf575f2">2</xref>
###xml 841 842 841 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf575f2">2</xref>
###xml 961 962 961 962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf575f2">2</xref>
###xml 1029 1030 1029 1030 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf575f2">2</xref>
Vertebrate telomerase RNA, including those of mammals, birds, fish, reptile and amphibians, vary significantly in length and sequence (26). However, phylogenetic analysis of these RNA sequences from distantly related telomerases show highly conserved structural domains and a remarkably similar core structure despite low primary sequence conservation (26). In particular, 8 nt in the catalytically important template domain are universally conserved throughout the vertebrate kingdom with the consensus sequence 3'-UCCCAAUC-5' (Fig. 2A). The template region of telomerase may be functionally divided into two distinct domains known as the alignment (italicised) and elongation domains. The elongation domain is invariant for all vertebrates and consists of the 6 nt sequence 3'-CCAAUC-5', which encodes the telomeric repeat d(GGTTAG) (Fig. 2A). The alignment domain of vertebrates is less conserved and has evolved to have lengths ranging from 2 to 5 nt (Fig. 2A). The sequence conservation of these residues is shown in Figure 2B.
###end p 7
###begin p 8
###xml 66 71 66 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CAAUC</italic>
###xml 371 372 371 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf575f1">1</xref>
###xml 376 378 376 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c20">20</xref>
###xml 379 381 379 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c27">27</xref>
###xml 906 908 906 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c28">28</xref>
###xml 909 911 909 911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c29">29</xref>
###xml 999 1001 999 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c18">18</xref>
###xml 1197 1199 1197 1199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c30">30</xref>
###xml 1200 1202 1200 1202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c33">33</xref>
###xml 25 30 <span type="species:ncbi:9606">human</span>
###xml 920 925 <span type="species:ncbi:9606">human</span>
###xml 1237 1242 <span type="species:ncbi:9606">human</span>
###xml 1367 1372 <span type="species:ncbi:9606">human</span>
###xml 1553 1558 <span type="species:ncbi:9606">human</span>
The template sequence of human telomerase is 11 residues long (3'-CAAUCCCAAUC-5'), nearly twice the length of a telomeric repeat. Phylogenetic analysis suggests a minimum of 8 nt may be sufficient for function in vertebrates. It has been postulated that the alignment domain functions to re-position the primer substrate by base pairing during processive synthesis (Fig. 1D) (20,27). This translocation step is unique to telomerase amongst the polymerases and represents one of the most intriguing features to understand at the molecular level. However, there is much to be elucidated about factors that influence translocation efficiency and enzyme processivity. Based on the current model, re-alignment of DNA at the alignment domain may be the key for efficient repeat addition. Interestingly, rodent telomerases which can only allow up to 2 bp to form during re-alignment are typically non-processive (28,29) whilst human telomerase which potentially uses 5 bp is significantly more processive (18). Does the shorter alignment domain account for the synthesis of shorter products? The functionally important determinants within the telomerase RNA template have been characterised in ciliates (30-33) but little has been reported for human telomerase. In this paper, we report studies on the effect of systematic reduction in the length of the alignment domain of human telomerase on activity with a particular emphasis on processivity. These studies also define a minimal requirement in the alignment domain for the processive catalytic activity of human telomerase.
###end p 8
###begin title 9
MATERIALS AND METHODS
###end title 9
###begin title 10
hTERT and hTR plasmid constructs
###end title 10
###begin p 11
###xml 124 126 124 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c34">34</xref>
###xml 283 286 283 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nde</italic>
###xml 292 295 292 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 367 370 367 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nde</italic>
###xml 376 379 376 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
The hTERT expression plasmid was generated by sub-cloning the wild-type hTERT coding region from the pCl-Neo-hTERT plasmid (34) (obtained from Dr R. Weinberg) using the forward primer 5'-CATATGCCGCGCGCTCCCCGCTG-3' and the reverse primer 5'-GAATTCTCAGTCCAGGATGGTCTTGA-3' containing a NdeI and EcoRI restriction site, respectively. The PCR fragments were digested with NdeI and EcoRI and subsequently cloned into plasmid pET28a digested with the same enzymes. This resulted in the pET28a-hTERT expression vector in which the hTERT insert is flanked 5' by a T7 RNA polymerase promoter.
###end p 11
###begin p 12
###xml 105 107 105 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c26">26</xref>
###xml 251 254 251 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hin</italic>
###xml 392 395 392 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 458 466 458 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 37 42 <span type="species:ncbi:9606">human</span>
The full-length (451 nt) RNA gene of human telomerase (hTR) was amplified from HeLa genomic DNA (Sigma) (26). A subsequent PCR amplification was carried out using the forward primer 5'-GGGGAAGCTTTAATACGACTCACTATAGGGTTGCGGAGGGTGGGCCTG-3', containing a HindIII site followed by the promoter for the T7 RNA polymerase, and the reverse primer 5'-CCCCGGATCCTGCGCATGTGTGAGCCGAGTCCTGG-3', bearing a BamHI restriction site. The PCR product was cloned into pUC18 for in vitro transcription, resulting in the pUC18-hTR+1 plasmid encoding for the wild-type RNA subunit of telomerase.
###end p 12
###begin title 13
Site-directed mutagenesis
###end title 13
###begin p 14
###xml 436 438 432 434 <sup xmlns:xlink="http://www.w3.org/1999/xlink">56</sup>
###xml 440 442 436 438 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 484 486 480 482 <underline xmlns:xlink="http://www.w3.org/1999/xlink">TG</underline>
###xml 537 539 533 535 <underline xmlns:xlink="http://www.w3.org/1999/xlink">CA</underline>
Mutations in hTR were performed on the pUC18-hTR+1 plasmid using the QuikChange site-directed mutagenesis kit according to the manufacturer's recommendations (Stratagene). Primers 5'-CCATTTTTTGTCTAACCCTATGAGAAGGGCGTAGGCG-3' (sense) and 5'-CGCCTACGCCCTTCTCATAGGGTTAGACAAAAAATGG-3' (antisense) were used to amplify plasmid pUC18-hTR+1 and gave plasmid pUC18-hTR-Delta2 bearing deletions in the first two residues of the alignment domain (56CA55). The primer pair 5'-CCATTTTTTGTCTAACCCTATGTGAGAAGGGCGTAGGC-3' (sense) and 5'-GCCTACGCCCTTCTCACATAGGGTTAGACAGTGG-3' (antisense) was used to amplify plasmid pUC18-hTR+1 giving rise to plasmid pUC18-hTR-sub2 with substitutions in the first two residues of the alignment domain of telomerase RNA. Similar primer sets containing the corresponding modifications were used to generate the other hTR variants described in this paper. Thermocycling was for 30 s at 95degreesC, followed by 15 cycles of 30 s at 95degreesC, 1 min at 55degreesC and 7 min at 68degreesC. All mutations were checked by sequencing of the corresponding plasmids.
###end p 14
###begin title 15
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro</italic>
###xml 45 50 <span type="species:ncbi:9606">human</span>
In vitro transcription and reconstitution of human telomerase activity
###end title 15
###begin p 16
###xml 121 124 121 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 136 144 136 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 200 203 200 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 306 307 302 303 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 79 84 <span type="species:ncbi:9606">human</span>
###xml 958 964 <span type="species:ncbi:9986">rabbit</span>
Plasmids containing the gene encoding the wild-type and mutant versions of the human telomerase RNA were linearised with BamHI prior to in vitro transcription. Plasmid pET28a-hTERT was digested using NotI. The transcription reaction (100 microl) contained 40 mM Tris-HCl, pH 8.0, 2 mM spermidine, 8 mM MgCl2, 50 mM NaCl, 30 mM dithiothreitol, 1 mM each NTP, 200 U RNAguard, 2 microg of linearized template DNA and 100 UT7 RNA polymerase (Stratagene). After 2 h incubation at 37degreesC, the DNA template was digested with 2.5 U/microg DNA of RNase-free DNase I (Amersham Pharmacia Biotech) for 10 min at 37degreesC. Free NTPs were removed by size exclusion chromatography (NAP-5 column; Amersham Pharmacia Biotech). Transcripts were precipitated with ethanol and dissolved in water prior to use. The integrity and size of the RNA transcripts were determined by staining with ethidium bromide. Telomerase activity was reconstituted using the nuclease-treated rabbit reticulocyte lysate system (RRL) (Promega) at 70% total concentration complemented with purified hTERT mRNA transcripts (25 ng/microl lysate) and wild-type or hTR variants (0.1 microg/microl lysate). Other components of the transcription mix were as recommended by the RRL manufacturer. The reaction mixtures were incubated for 90 min at 30degreesC and either assayed immediately for activity or quick frozen and kept at -78degreesC until use.
###end p 16
###begin title 17
###xml 27 32 <span type="species:ncbi:9606">human</span>
Primer extension assays of human telomerase activity
###end title 17
###begin p 18
###xml 139 140 135 136 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 282 284 266 268 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 339 341 323 325 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 887 890 861 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Taq</italic>
###xml 976 977 946 947 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 203 209 <span type="species:ncbi:9986">rabbit</span>
The TRAP assay (Intergen) was performed in 50 microl total volume containing 1x CHAPS buffer (20 mM Tris-HCl pH 8.3, 63 mM KCl, 1.5 mM MgCl2, 0.05% v/v Tween-20, 1 mM EGTA), 50 microM dNTPs, 2 microl of rabbit reticulocyte lysate unless otherwise mentioned and 0.1 microg of either 32P-radiolabeled TS primer (5'-AATCCGTCGAGCAGAGTT-3') or 32P-radiolabeled primers identical in sequence to the original TS oligonucleotide other than the terminal 3' nucleotides dGTT, which were substituted by either dGGT or dGGG. Each reaction mixture was incubated for 45 min at 30degreesC. The telomerase products were phenol/chloroform extracted and ethanol precipitated or alternatively purified using the QIAquick Nucleotide Removal Kit (Qiagen) and dissolved in PCR-grade water prior to amplification. PCR amplification was also carried out in 50 microl total volume including 1x CHAPS buffer, 2 U Taq polymerase (Amersham Pharmacia Biotech), 0.1 microg reverse primer [5'-GCGCGG(CTTACC)3CTAACC-3'], 0.01 amol internal control (IC) primer (5'-AATCCGTCGAGCAGAGTTAAAAGGCCGAGAAGCGAT-3') and 0.1 microg IC specific reverse primer (5'-ATCGCTTCTCGGCCTTTT-3'). Each reaction mixture was placed in a pre-heated GENEAMP 2400 thermocycler block for 28 cycles at 94degreesC for 30 s, 59degreesC for 30 s and 72degreesC for 30 s, followed by 8 min at 72degreesC. The PCR products were separated on a 12.5% non-denaturing polyacrylamide gel. The gels were dried and exposed for autoradiography for 12-24 h. The reaction products were visualised and quantitated using a phosphorimager (Molecular Dynamic) and the densitometric analysis was performed with the ImageQuant v.3.0 software. The signal intensity in the RRL control [lysate (-hTR, +hTERT)] was subtracted as background. All the results given in this paper are the average from at least three independent experiments unless otherwise mentioned.
###end p 18
###begin p 19
###xml 69 74 69 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 77 79 77 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c35">35</xref>
###xml 302 303 298 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i</italic>
###xml 319 320 315 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 320 321 316 317 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 343 344 322 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T</italic>
###xml 344 349 323 328 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i + 1</sub>
###xml 352 353 331 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T</italic>
###xml 353 358 332 337 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i + 2</sub>
###xml 373 374 344 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T</italic>
###xml 374 375 345 346 <sub xmlns:xlink="http://www.w3.org/1999/xlink">n</sub>
###xml 396 397 350 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T</italic>
###xml 397 398 351 352 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 401 402 355 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T</italic>
###xml 402 407 356 361 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i + 1</sub>
###xml 422 423 368 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T</italic>
###xml 423 424 369 370 <sub xmlns:xlink="http://www.w3.org/1999/xlink">n</sub>
###xml 433 434 379 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T</italic>
###xml 434 435 380 381 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 470 471 416 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 471 472 417 418 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 511 512 457 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 592 594 538 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c35">35</xref>
The modified version of the TRAP was performed as described by Aradi et al. (35) using 2 microl of RRL. The DNA products of telomerase extension were purified prior to amplification and analysed as described above. For a quantitative comparison of processivity, the processivity of a particular repeat i was defined as Pi = summation operator(Ti + 1 + Ti + 2 + em leader + Tn)/summation operator(Ti + Ti + 1 + em leader + Tn), where Ti designated the signal of position Pi determined using a phosphorimager and n designated the highest number of repeats discernable on the telomerase ladder (35).
###end p 19
###begin title 20
Competitive inhibition of the wild-type hTR-protein complex formation
###end title 20
###begin p 21
###xml 223 228 <span type="species:ncbi:9606">human</span>
Reconstitution of telomerase activity was performed as described above in the absence or presence of increasing amounts of competitor RNA (up to 50-fold molar excess). The competitor RNAs (Delta4 or Delta5) or non-specific human transfer RNA (tRNA from Sigma) were added to the RRL in conjunction with wild-type hTR and before translation of hTERT. The total amount of RNA within each reaction mix was kept constant at a concentration of 0.1 microg/microl lysate used. Activity was assayed immediately after incubation using 2 microl of lysate and quantified as described above.
###end p 21
###begin title 22
RESULTS
###end title 22
###begin p 23
###xml 158 160 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c18">18</xref>
###xml 263 265 263 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c18">18</xref>
###xml 266 268 266 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c36">36</xref>
###xml 274 279 274 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vitro</italic>
###xml 451 453 451 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c37">37</xref>
###xml 454 456 454 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c38">38</xref>
###xml 497 505 497 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 797 798 789 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkf575tb1">1</xref>
###xml 1230 1232 1222 1224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c35">35</xref>
###xml 1233 1235 1225 1227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c39">39</xref>
###xml 1452 1454 1444 1446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c39">39</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human telomerase elongates DNA substrates with tandemly repeated telomeric sequences d(GGTTAG) generating a characteristic ladder with a periodicity of 6 nt (18). The bands on the ladder arise from pausing and/or dissociation events during the extension process (18,36). In vitro co-expression of the RNA subunit (TR) and protein reverse transcriptase (TERT) component of telomerase in RRL suffices to reconstitute wild-type-like telomerase activity (37,38). Telomerase activity was reconstituted in vitro with a fixed amount (0.1 microg/microl lysate) of either wild-type or mutated RNAs using the RRL expression system. To study the alignment domain requirements, the effects of both deletions and substitutions at the 3' end of the alignment domain on telomerase activity were evaluated (Table 1). An important aspect of the experimental design is that systematic alterations from the 3' end simply reduce the length of the alignment sequence, but without causing internal mismatches or discontinuity between alignment and templating sequences, which may also interfere with telomerase function. Assays were performed by either the standard TRAP or an adapted protocol using recombinant telomerase (see Materials and Methods) (35,39). Products were separated by gel electrophoresis and quantified by integrating the radioactive signal of the ladder in each lane divided by the signal from the respective internal control as described by Kim and Wu (39). The activity for all the mutants was background corrected (see Materials and Methods) and normalised relative to telomerase activity reconstituted by wild-type hTR, which represents 100% activity.
###end p 23
###begin title 24
###xml 49 54 <span type="species:ncbi:9606">human</span>
3'-Terminal deletions in the alignment domain of human telomerase
###end title 24
###begin p 25
###xml 42 44 42 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink">56</sup>
###xml 49 51 49 51 <sup xmlns:xlink="http://www.w3.org/1999/xlink">52</sup>
###xml 225 230 225 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 233 235 233 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c40">40</xref>
###xml 313 314 313 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkf575tb1">1</xref>
###xml 58 63 <span type="species:ncbi:9606">human</span>
The pentanucleotide alignment sequence 3'-56CAAUC52-5' of human telomerase was systematically shortened by the deletion of residues from the 3' end. The numbering of hTR nucleotides is based on the sequence described by Feng et al. (40). All the mutants constructed and discussed in this paper are given in Table 1.
###end p 25
###begin p 26
###xml 33 35 33 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink">56</sup>
###xml 157 158 151 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkf575tb1">1</xref>
###xml 168 169 162 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf575f3">3</xref>
###xml 221 223 215 217 <sup xmlns:xlink="http://www.w3.org/1999/xlink">56</sup>
###xml 225 227 219 221 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 278 279 266 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf575f3">3</xref>
###xml 390 392 378 380 <sup xmlns:xlink="http://www.w3.org/1999/xlink">56</sup>
###xml 395 397 383 385 <sup xmlns:xlink="http://www.w3.org/1999/xlink">54</sup>
###xml 417 419 401 403 <sup xmlns:xlink="http://www.w3.org/1999/xlink">56</sup>
###xml 423 425 407 409 <sup xmlns:xlink="http://www.w3.org/1999/xlink">53</sup>
###xml 487 489 467 469 <sup xmlns:xlink="http://www.w3.org/1999/xlink">56</sup>
###xml 494 496 474 476 <sup xmlns:xlink="http://www.w3.org/1999/xlink">52</sup>
###xml 568 569 544 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkf575tb1">1</xref>
###xml 579 580 555 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf575f3">3</xref>
###xml 693 694 669 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf575f3">3</xref>
###xml 752 753 728 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkf575tb1">1</xref>
###xml 776 778 752 754 <sup xmlns:xlink="http://www.w3.org/1999/xlink">56</sup>
###xml 945 947 921 923 <sup xmlns:xlink="http://www.w3.org/1999/xlink">56</sup>
###xml 949 951 925 927 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 1164 1166 1140 1142 <sup xmlns:xlink="http://www.w3.org/1999/xlink">54</sup>
###xml 1169 1171 1145 1147 <sup xmlns:xlink="http://www.w3.org/1999/xlink">52</sup>
Deletion of the first nucleotide 56C (mutant hereafter referred to as Delta1) decreased the catalytic activity to 84 +/- 8% as measured by TRAP assay (Table 1 and Fig. 3, lane 6). Deletion of the dinucleotide sequence 3'-56CA55-5' (Delta2) decreased activity to 43 +/- 9% (Fig. 3, lane 7). Further shortening of the alignment domain by deletion of the tri- and tetranucleotide sequences 3'-56CAA54-5' (Delta3) and 3'-56CAAU53-5' (Delta4) respectively or deletion of all five residues 3'-56CAAUC52-5' (Delta5) resulted in no detectable activity above background (Table 1 and Fig. 3, lanes 8-10, respectively). A low level of background activity (3%) endogeneous to the RRL was detectable (Fig. 3, lane 12) and all data were corrected accordingly (Table 1). Deletion of residue 56C does not significantly impair telomerase activity, suggesting that this residue makes a minor contribution to overall activity. Similarly, the dinucleotide sequence 56CA55 is required but not essential for overall activity. The progressive decrease in overall activity with reduced alignment domain reaches a critical cut-off point at 3 nt, corresponding to the remaining sequence 3'-54AUC52-5', where further length reduction leads to complete loss of activity.
###end p 26
###begin p 27
###xml 330 332 330 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c39">39</xref>
###xml 602 604 602 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c39">39</xref>
###xml 723 725 723 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c39">39</xref>
###xml 907 908 899 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf575f4">4</xref>
###xml 1182 1184 1166 1168 <sup xmlns:xlink="http://www.w3.org/1999/xlink">56</sup>
###xml 1209 1211 1193 1195 <sup xmlns:xlink="http://www.w3.org/1999/xlink">56</sup>
###xml 1213 1215 1197 1199 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 1449 1451 1433 1435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c35">35</xref>
###xml 1760 1762 1744 1746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c35">35</xref>
###xml 1972 1973 1948 1949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf575f4">4</xref>
###xml 2082 2083 2058 2059 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf575f3">3</xref>
###xml 1265 1270 <span type="species:ncbi:9606">human</span>
Analysis of the elongation products provides information on telomerase processivity. The TRAP assay conditions include a large excess of primer, such that repeats added to any given primer will result from a single primer-binding event, with synthesis effectively terminating for a given primer upon dissociation from the enzyme (39). Although the original distribution of DNA products from the telomerase extension is subject to scrambling (owing to multiple reverse primer-binding sites during the PCR amplification), the overall method occurs without further lengthening of the telomerase products (39). The TRAP may therefore provide a qualitative measure of processivity by counting the longest repeats on the ladder (39). Gel electrophoresis analysis of the telomerase ladder from wild-type telomerase and the Delta1 and Delta2 mutant enzymes revealed a comparable pattern of product elongation (Fig. 4, lanes 5-7, respectively). In particular, the longest products generated by the Delta1 and Delta2 mutants are comparable in size to those generated by the wild-type enzyme (approximately 20 added repeats), indicative of similar processivity. Therefore, deletion of residue 56C or of the dinucleotide 56CA55 does not significantly alter the processivity of human telomerase. Further confirmation of these results was obtained using a modified version of the TRAP specially developed by Szatmari and Aradi to analyse telomerase processivity (35). The assay includes a step which caps the 3' ends of the telomerase extension products prior to PCR amplification. The PCR amplification uses a reverse primer complementary to the unique capping sequence and thus preserves both the initial size and length distribution of the telomerase extension products (35). Using this method, qualitative analysis of the products ladder indicated that the longest products generated by the Delta1 and Delta2 mutants were comparable to those generated by the wild-type enzyme (Fig. 4A, lanes 3, 4 and 6, respectively), consistent with the data obtained with the conventional TRAP assay (Fig. 3).
###end p 27
###begin p 28
###xml 102 104 102 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c35">35</xref>
###xml 273 274 273 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf575f4">4</xref>
###xml 320 321 320 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf575f5">5</xref>
###xml 330 331 330 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 331 332 331 332 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 398 399 398 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i</italic>
###xml 439 440 439 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 440 441 440 441 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 443 444 443 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 444 445 444 445 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 447 448 447 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 448 449 448 449 <sub xmlns:xlink="http://www.w3.org/1999/xlink">9</sub>
###xml 454 455 454 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 455 457 455 457 <sub xmlns:xlink="http://www.w3.org/1999/xlink">10</sub>
###xml 583 584 575 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf575f4">4</xref>
###xml 698 700 690 692 <sup xmlns:xlink="http://www.w3.org/1999/xlink">56</sup>
###xml 711 713 703 705 <sup xmlns:xlink="http://www.w3.org/1999/xlink">56</sup>
###xml 715 717 707 709 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 763 768 <span type="species:ncbi:9606">human</span>
A quantitative analysis of processivity was also carried out (as described in Materials and Methods) (35). The first and second visible repeat of a given ladder were chosen as representative of the short products and repeats 9 and 10 were chosen as the long products (Fig. 4A, arrows). The data are summarised in Figure 5B, where Pi designates the processivity of telomerase at a particular repeat i of the ladder. The processivity values P1, P2, P9 and P10 for the mutant enzymes Delta1 and Delta2 and wild-type recombinant telomerase were identical within experimental error (Fig. 4B). Taken together, these results further confirm that shortening of the alignment domain from the 3' end by one (56C) or two (56CA55) residues does not alter the processivity of human telomerase.
###end p 28
###begin p 29
###xml 164 166 164 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c39">39</xref>
###xml 586 587 566 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf575f4">4</xref>
###xml 625 627 605 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c35">35</xref>
###xml 1279 1281 1239 1241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c18">18</xref>
###xml 1282 1284 1242 1244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c25">25</xref>
###xml 1415 1416 1375 1376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf575f5">5</xref>
PCR amplification of the telomerase products by the standard TRAP assay is restricted to detecting extension products that contain at least four telomeric repeats (39). Therefore, a poorly processive enzyme activity cannot be precluded for mutants Delta3-Delta5. In an attempt to detect low levels of poor processive activity for mutant enzymes Delta3, Delta4 and Delta5, we have either used 10-fold more enzyme in the assay to enhance detection sensitivity (data not shown) or employed the modified TRAP capable of amplifying a primer extended by as few as two telomeric repeats (Fig. 4A, lanes 8, 10 and 12, respectively) (35). Neither attempt resulted in detectable level of telomerase product for Delta3, Delta4 and Delta5 variants, thus reflecting a serious impairment of activity and/or processive synthesis for these mutant enzymes. In addition, wild-type and mutant telomerases (Delta1-Delta5) were also assayed with alternative primers (TS-GGT and TS-GGG) identical in sequence to the original TS except that the terminal 3' nucleotides dGTT were substituted by the trinucleotides dGGT and dGGG, respectively. These primers are designed to base pair with the elongation domain only, which remained unchanged, and thus normalise the first round synthesis in all mutants (18,25). The levels and patterns of reconstituted catalytic activity observed were comparable to those described for the TS primer (Fig. 5), indicating that the effects of mutations are general to all three DNA substrates.
###end p 29
###begin title 30
###xml 65 70 <span type="species:ncbi:9606">human</span>
3'-Terminal substitutions of residues in the alignment domain of human telomerase
###end title 30
###begin p 31
###xml 515 516 515 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkf575tb1">1</xref>
###xml 630 632 630 632 <sup xmlns:xlink="http://www.w3.org/1999/xlink">56</sup>
###xml 685 686 683 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkf575tb1">1</xref>
###xml 696 697 694 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf575f6">6</xref>
###xml 724 726 722 724 <sup xmlns:xlink="http://www.w3.org/1999/xlink">56</sup>
###xml 728 730 726 728 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 803 804 799 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf575f6">6</xref>
###xml 854 856 850 852 <sup xmlns:xlink="http://www.w3.org/1999/xlink">56</sup>
###xml 859 861 855 857 <sup xmlns:xlink="http://www.w3.org/1999/xlink">54</sup>
###xml 877 879 873 875 <sup xmlns:xlink="http://www.w3.org/1999/xlink">56</sup>
###xml 883 885 879 881 <sup xmlns:xlink="http://www.w3.org/1999/xlink">53</sup>
###xml 905 907 901 903 <sup xmlns:xlink="http://www.w3.org/1999/xlink">56</sup>
###xml 912 914 908 910 <sup xmlns:xlink="http://www.w3.org/1999/xlink">52</sup>
###xml 1032 1033 1028 1029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkf575tb1">1</xref>
###xml 1043 1044 1039 1040 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf575f6">6</xref>
###xml 1282 1288 1278 1284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">per se</italic>
It is possible that the deletion of residues from the alignment domain of hTR may inadvertently disrupt telomerase activity by possibly frame-shifting the RNA template with respect to the active site of telomerase protein. To rule out this possibility, we generated and studied a series of RNA variants in which residues in the alignment domain have been substituted from the 3' end by analogy with the deletions. For the substitution mutants, purines were replaced by pyrimidines and pyrimidines by purines (Table 1). The activity of reconstituted telomerase mutants was measured as described previously. Substitution of residue 56C by G (Sub1) decreased activity to 77 +/- 3% (Table 1 and Fig. 6, lane 6). Substitution of 56CA55 by GT (Sub2) resulted in 37 +/- 7% activity compared to wild-type (Fig. 6, lane 7). Further substitutions of the sequences 56CAA54 by GTT (Sub3), 56CAAU53 by GTTA (Sub4) and 56CAAUC52 by GTTAG (Sub5) in the alignment domain resulted in no telomerase activity detectable above background levels (Table 1 and Fig. 6, lanes 8-10). These results are identical, within experimental error, to those obtained for the corresponding deletion mutants and support the hypothesis that observed changes in activity result from shortening of the alignment sequence per se rather than non-specific effects due a change in register between the template and the active site of hTERT.
###end p 31
###begin p 32
###xml 99 100 99 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf575f4">4</xref>
###xml 352 354 352 354 <sup xmlns:xlink="http://www.w3.org/1999/xlink">54</sup>
###xml 357 359 357 359 <sup xmlns:xlink="http://www.w3.org/1999/xlink">52</sup>
###xml 691 692 691 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf575f4">4</xref>
###xml 791 792 791 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 792 793 792 793 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 795 796 795 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 796 797 796 797 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 799 800 799 800 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 800 801 800 801 <sub xmlns:xlink="http://www.w3.org/1999/xlink">9</sub>
###xml 806 807 806 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 807 809 807 809 <sub xmlns:xlink="http://www.w3.org/1999/xlink">10</sub>
###xml 1022 1024 1022 1024 <sup xmlns:xlink="http://www.w3.org/1999/xlink">56</sup>
###xml 1030 1032 1030 1032 <sup xmlns:xlink="http://www.w3.org/1999/xlink">56</sup>
###xml 1034 1036 1034 1036 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 1067 1068 1067 1068 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf575f4">4</xref>
###xml 467 472 <span type="species:ncbi:9606">human</span>
We also assayed the mutant enzymes Sub3, Sub4 and Sub5 with the modified version of the TRAP (Fig. 4A, lanes 9, 11 and 13, respectively). In good agreement with the deletion experiments, we found that the Sub3, Sub4 and Sub5 mutants did not generate any detectable level of products above background, further indicating that the trinucleotide sequence 54AUC52 is apparently absolutely critical and represents the minimum length requirement of the alignment domain of human telomerase for efficient extension. Qualitative analysis of the telomerase ladder generated by the mutants Sub1 and Sub2 confirmed that these mutants and wild-type telomerase generated identical product profiles (Fig. 4A, lanes 3, 5 and 7). This was further supported by our quantitation data of processivity, whereby P1, P2, P9 and P10 of both mutants Sub1 and Sub2 were identical within experimental error to wild-type telomerase, further demonstrating that the processivity of telomerase is not sensitive to modifications of the most 3' residues 56C and 56CA55 of the alignment domain (Fig. 4B).
###end p 32
###begin title 33
###xml 23 28 <span type="species:ncbi:9606">human</span>
Specific inhibition of human telomerase ribonucleoprotein formation
###end title 33
###begin p 34
###xml 220 222 220 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c41">41</xref>
###xml 223 225 223 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c42">42</xref>
###xml 490 491 486 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf575f7">7</xref>
###xml 1060 1061 1040 1041 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf575f7">7</xref>
###xml 1333 1334 1301 1302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf575f7">7</xref>
###xml 1463 1464 1427 1428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf575f7">7</xref>
###xml 1592 1593 1556 1557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf575f7">7</xref>
###xml 1699 1701 1663 1665 <sup xmlns:xlink="http://www.w3.org/1999/xlink">56</sup>
###xml 1706 1708 1670 1672 <sup xmlns:xlink="http://www.w3.org/1999/xlink">52</sup>
###xml 1490 1495 <span type="species:ncbi:9606">human</span>
###xml 1968 1973 <span type="species:ncbi:9606">human</span>
To preclude the possibility that changes in activity may result from a failure of mutant hTR to bind hTERT protein, we carried out a competition assay to determine the ability of the RNA variants to interact with hTERT (41,42). Specifically, we investigated whether the most drastically altered RNA variant Delta5 could compete with wild-type hTR for the formation of the RNA-hTERT complex, by testing the level of activity reconstituted in the absence and presence of competitor RNA (Fig. 7). Standard competition assays were performed with a fixed amount of total RNA (0.1 microg/microl lysate) in the presence of increasing amounts of the competitor RNA Delta5 (1-, 10-, 20- and 50-fold molar excess). Both RNAs were added simultaneously to the RRL prior to hTERT translation and the reconstituted telomerase activity measured by TRAP as described above. Telomerase activity reconstituted in the presence of Delta5 was significantly reduced in a concentration-dependent manner, indicating a specific competition with wild-type hTR for protein binding (Fig. 7, lanes 2-6). In particular, telomerase reconstituted in the presence of a 20-fold molar excess of competitor Delta5 was very weakly active relative to telomerase reconstituted with wild-type hTR alone at the corresponding concentration (0.005 microg/microl lysate) (Fig. 7, compare lanes 5 and 8, respectively). The variant RNA Delta4 was equally able to specifically compete with wild-type hTR (Fig. 7, lanes 9 and 10), whilst human tRNA (20-fold molar excess) had no effect on the telomerase RNA-protein complex formation (Fig. 7, lane 11). These results indicate that the deletion of four or five residues from the alignment sequence 56CAAUC52 does not preclude the ability of the RNA mutants to associate with hTERT. Therefore, the observation that certain hTR variants do not support catalytic activity in RRL are unlikely to be simply due to the inability of the RNA to bind the protein component of human telomerase.
###end p 34
###begin title 35
DISCUSSION
###end title 35
###begin p 36
###xml 42 44 42 44 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c12">12</xref>
###xml 45 47 45 47 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c43">43</xref>
###xml 66 68 66 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c44">44</xref>
###xml 139 141 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c45">45</xref>
###xml 218 220 218 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c46">46</xref>
###xml 403 404 403 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf575f1">1</xref>
###xml 407 409 407 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c40">40</xref>
###xml 485 490 485 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CAAUC</italic>
###xml 710 711 710 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf575f2">2</xref>
###xml 715 717 715 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c26">26</xref>
###xml 718 720 718 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c47">47</xref>
###xml 807 809 807 809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c26">26</xref>
###xml 892 893 892 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf575f2">2</xref>
###xml 1051 1052 1051 1052 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf575f2">2</xref>
###xml 1207 1209 1207 1209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UC</italic>
###xml 1251 1256 1251 1256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CAAUC</italic>
###xml 1278 1279 1278 1279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf575f2">2</xref>
###xml 129 134 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 435 440 <span type="species:ncbi:9606">human</span>
###xml 1265 1271 <span type="species:ncbi:9606">humans</span>
###xml 1358 1363 <span type="species:ncbi:9606">human</span>
Telomerase shares significant structural (12,43) and mechanistic (44) traits with retroviral reverse transcriptases (RT) such as HIV-1 RT (45), but there are features that clearly distinguish it from conventional RTs (46). Most notably, telomerase carries an intrinsic RNA component which, in addition to structural functions, contains the template sequence that directs telomere repeat synthesis (Fig. 1) (40). The template region of human telomerase consists of an 11 nt sequence 3'-CAAUCCCAAUC-5' complementary to nearly two telomeric repeats d(GGTTAG). The template sequences of other vertebrates vary in length, ranging from 11 to 8 nt, suggesting that 8 nt maybe sufficient for telomerase function (Fig. 2A) (26,47). Of these eight residues, six form a universally conserved (100% sequence identity) (26) elongation domain (3'-CCAAUC-5') which codes for a single telomeric repeat (Fig. 2A). The alignment domain, contiguous to the 3' end of the elongation domain, consists of additional nucleotides complementary to the telomeric sequence (Fig. 2A). Unlike the elongation domain, the alignment domain of telomerase is not completely conserved throughout vertebrates and varies in length from 2 nt (3'-UC-5') for rodents to a maximum of 5 nt (3'-CAAUC-5') for humans (Fig. 2A). This strongly suggests that not all nucleotides in the alignment domain of human telomerase are required for function.
###end p 36
###begin p 37
###xml 110 112 110 112 <sup xmlns:xlink="http://www.w3.org/1999/xlink">56</sup>
###xml 118 120 118 120 <sup xmlns:xlink="http://www.w3.org/1999/xlink">56</sup>
###xml 122 124 122 124 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 222 224 222 224 <sup xmlns:xlink="http://www.w3.org/1999/xlink">56</sup>
###xml 332 334 330 332 <sup xmlns:xlink="http://www.w3.org/1999/xlink">56</sup>
###xml 336 338 334 336 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 464 465 446 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkf575tb1">1</xref>
###xml 475 476 457 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf575f3">3</xref>
###xml 545 547 527 529 <sup xmlns:xlink="http://www.w3.org/1999/xlink">56</sup>
###xml 553 555 535 537 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 698 706 680 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 986 988 968 970 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c18">18</xref>
###xml 989 991 971 973 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c25">25</xref>
###xml 1283 1284 1265 1266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf575f5">5</xref>
###xml 2095 2097 2077 2079 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c26">26</xref>
###xml 49 54 <span type="species:ncbi:9606">human</span>
###xml 584 589 <span type="species:ncbi:9606">human</span>
###xml 926 931 <span type="species:ncbi:9606">human</span>
Altering the sequence of the alignment domain of human telomerase at the first two positions from the 3' end (56C and 56CA55, respectively) influences some aspects of telomerase activity. Deletion of the first 3' residue (56C) of the alignment domain marginally reduced overall activity to 84 +/- 8% whilst deletion of the sequence 56CA55 (mutant Delta2) had a more pronounced effect, but the decrease in overall activity was still of only approximately50% (Table 1 and Fig. 3). These observations demonstrate that the most 3' terminal residues 56C and 55A of the alignment domain of human telomerase do contribute to the optimal function of telomerase but are not essential for catalytic activity in vitro. Each mutant was assayed with three alternative primers differing just in their three most 3' terminal nucleotides. Two of these primers (TS-GGT and TS-GGG) were designed to base pair only with the elongation domain of human telomerase, which remained unaltered for all mutants (18,25). The initial primer recognition was therefore normalised during first round synthesis for all the mutants, which helps preclude changes in activity that would result purely from initiation. Comparable levels of activity and processivity profiles were generated with all three primers (Fig. 5), indicating that the variations in telomerase activity between the mutants reflect intrinsic biochemical properties of the core enzymes. The substitution mutants Sub1 and Sub2 show activities comparable to the corresponding deletions, which supports the hypothesis that the changes in activity relate to shortening of the alignment sequence, rather than a potential change in register between the RNA template and the catalytic core of the protein which might arise upon nucleotide deletion. This also indicates a tolerance in the hTR structure towards slight modifications in the region between the template and the upstream conserved pseudoknot structure (spanning nucleotides 57-64). This is consistent with the fact that the length of this particular region is not conserved in vertebrate telomerase RNA (26).
###end p 37
###begin p 38
###xml 63 65 63 65 <sup xmlns:xlink="http://www.w3.org/1999/xlink">56</sup>
###xml 71 73 71 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 188 189 188 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf575f4">4</xref>
###xml 698 700 698 700 <sup xmlns:xlink="http://www.w3.org/1999/xlink">56</sup>
###xml 706 708 706 708 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 770 771 762 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 814 816 794 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c48">48</xref>
###xml 986 988 966 968 <sup xmlns:xlink="http://www.w3.org/1999/xlink">54</sup>
###xml 991 993 971 973 <sup xmlns:xlink="http://www.w3.org/1999/xlink">52</sup>
###xml 1225 1236 1205 1216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tetrahymena</italic>
###xml 1238 1240 1218 1220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c49">49</xref>
###xml 1241 1243 1221 1223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c50">50</xref>
###xml 931 936 <span type="species:ncbi:9606">human</span>
###xml 1124 1129 <span type="species:ncbi:9606">human</span>
###xml 1215 1220 <span type="species:ncbi:4932">yeast</span>
Interestingly, deletion or substitution of the first 1 or 2 nt 56C and 55A of the alignment sequence did not alter the processivity of the enzyme as compared to wild-type telomerase (Fig. 4). If repeat addition processivity is dependent on the re-alignment efficiency, one might have expected that a longer alignment domain, providing more base pairs, would favour repeat addition synthesis. The finding that processivity was insensitive to a loss of base-pairing potential from the first 2 nt, out of a total of 5 nt, of the alignment domain challenges this model. If DNA primers are re-aligned exclusively by base-pairing interaction during processive synthesis then loss of base pairing to both 56C and 55A would result in an estimated loss in free energy (DeltaDeltaGdegrees) of +1.9 kcal/mol (at 37degreesC) (48). Our data do not support that having a 4 or 5 nt long alignment domain is beneficial for processive synthesis of human telomerase, but rather that the 3 nt sequence 3'-54AUC52-5' is sufficient for repeat addition with an efficiency comparable to wild-type telomerase. Non-base-pairing interactions between human telomerase and the DNA substrate may exist near to the alignment domain, as shown in yeast and Tetrahymena (49,50), cooperating with base pairing to position the 3' end of the primer at the catalytic site. It is possible that such interactions could compensate for the difference in binding energy between the 3 and 5 bp hybrid duplex, thus allowing mutants Delta1, Delta2, Sub1 and Sub2 to display wild-type-like processivity.
###end p 38
###begin p 39
###xml 52 54 52 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 201 203 201 203 <sup xmlns:xlink="http://www.w3.org/1999/xlink">56</sup>
###xml 206 208 206 208 <sup xmlns:xlink="http://www.w3.org/1999/xlink">54</sup>
###xml 363 371 363 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 411 413 411 413 <sup xmlns:xlink="http://www.w3.org/1999/xlink">52</sup>
###xml 415 417 415 417 <sup xmlns:xlink="http://www.w3.org/1999/xlink">54</sup>
###xml 666 668 658 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c36">36</xref>
###xml 669 671 661 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c51">51</xref>
###xml 880 881 864 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf575f7">7</xref>
###xml 1540 1541 1516 1517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf575f4">4</xref>
###xml 1849 1851 1825 1827 <sup xmlns:xlink="http://www.w3.org/1999/xlink">54</sup>
###xml 1854 1856 1830 1832 <sup xmlns:xlink="http://www.w3.org/1999/xlink">52</sup>
###xml 1922 1945 1898 1921 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tetrahymena thermophila</italic>
###xml 2105 2107 2081 2083 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c31">31</xref>
###xml 2139 2152 2115 2128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T.thermophila</italic>
###xml 2555 2563 2531 2539 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 2565 2567 2541 2543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c29">29</xref>
###xml 2599 2601 2575 2577 <sup xmlns:xlink="http://www.w3.org/1999/xlink">54</sup>
###xml 2603 2605 2579 2581 <sup xmlns:xlink="http://www.w3.org/1999/xlink">52</sup>
###xml 337 342 <span type="species:ncbi:9606">human</span>
###xml 1756 1761 <span type="species:ncbi:9606">human</span>
###xml 1922 1945 <span type="species:ncbi:5911">Tetrahymena thermophila</span>
###xml 2139 2152 <span type="species:ncbi:5911">T.thermophila</span>
###xml 2219 2224 <span type="species:ncbi:9606">human</span>
Shortening of the alignment sequence beyond residue 55A had marked qualitative and quantitative effects on catalytic activity. In particular, the specific deletion or substitution of the trinucleotide 56CAA54 completely abolished enzymatic activity, clearly indicating that the minimal length of the alignment domain required to sustain human telomerase activity in vitro is three residues spanning nucleotides 52C-54A. Subsequently, mutants Delta4, Delta5, Sub4 and Sub5 were all judged inactive by both the conventional and modified TRAP assays. Despite the fact that none of the modified RNA residues were in a domain predicted to be involved in protein binding (36,51), we performed a competition assay to show that even the most significantly altered RNA variants, Delta4 and Delta5, bind specifically to telomerase protein with an affinity comparable to wild-type hTR (Fig. 7, lanes 2-10). Therefore, it is very unlikely that the defects in reconstituting telomerase activity with some of the RNA mutants was due to the inability of these RNA variants to associate with hTERT. In addition, increasing the quantity of enzyme used in the assays by 10-fold still showed no activity, suggesting a drop in activity of >2 orders of magnitude for mutants Delta4, Delta5, Sub4 and Sub5. Activity loss was independent of the three DNA primers used as substrate for telomerase extension, suggesting that the effect cannot be simply due to initial primer recognition. The modified TRAP, capable of detecting as few as two repeats addition (Fig. 4B, lanes 8-13), also failed to show activity. Taken together, the fact that an initiation problem during first round synthesis is unlikely and the absence of even two repeat addition products strongly suggests that human telomerase mutants with an alignment domain shorter than the trinucleotide sequence 3'-54AUC52-5' is unable to carry out post-first round synthesis. Studies on Tetrahymena thermophila have shown that shortening the alignment domain from 3 (wild-type) to 2 and 1 nt greatly impair multiple repeat synthesis while sustaining catalytic activity (31). Although the sequence of the T.thermophila telomerase alignment domain is not totally conserved with that of human telomerase, both enzymes are known to be normally very processive, suggesting that a 3 nt alignment domain may be a general minimum requirement of telomerases for processive synthesis. This is also consistent with the observation that most rodent telomerases, which have only a 2 nt alignment domain, are typically non-processive in vitro (29). The dinucleotide sequence 3'-54UC52-5' of the rodent telomerase alignment domain is the shortest known alignment sequence, which may be the minimum alignment domain for basic catalytic activity of telomerase.
###end p 39
###begin p 40
###xml 128 130 128 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c25">25</xref>
###xml 570 572 570 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c22">22</xref>
###xml 573 575 573 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c24">24</xref>
###xml 576 578 576 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c52">52</xref>
###xml 1466 1468 1466 1468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c25">25</xref>
###xml 712 717 <span type="species:ncbi:9606">human</span>
###xml 1142 1147 <span type="species:ncbi:9606">human</span>
###xml 1323 1328 <span type="species:ncbi:9606">human</span>
The alignment domain and the anchor site are both important sites for primer interaction with the telomerase ribonucleoprotein (25). Interactions of the telomerase product with these binding sites are likely to determine whether re-alignment and further elongation or dissociation is most likely. Anchor site interactions may be especially important for telomerase function in ciliates, since the development of macronuclei and chromosome healing events frequently require the extension of DNA substrates whose 3' termini are not complementary to the template sequence (22,24,52). However, little is known about the relative contribution of the anchor site and alignment domain interactions with the primers for human telomerase. Our results suggest that at least 3 bp of the DNA substrate with the RNA template is required for efficient re-alignment and processive synthesis. These results imply that deletion of three or more residues from the alignment domain may destabilise the product DNA-alignment domain heteroduplex favouring product release from the enzyme. In light of our results, it would appear that for processivity control in human telomerase, the anchor site might only play a role secondary to the alignment domain. This is in good agreement with observations previously made that a strong interaction of human telomerase at the anchor site is insufficient to overcome a limited base-pairing interaction between the primer 3' end and the template (25). By gradually deleting residues from the 3' end of the DNA primer, Morin demonstrated that as few as two base-pairing interactions in the last 4 nt suffice for initiation and elongation by telomerase. While those primer modifications only affected first round synthesis (i.e. primer recognition), our study complements these findings and suggest that at least three base-pairing interactions are required for efficient synthesis in subsequent rounds of primer extension.
###end p 40
###begin p 41
###xml 128 141 128 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T.thermophila</italic>
###xml 146 162 146 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Euplotes crassus</italic>
###xml 164 166 164 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c53">53</xref>
###xml 1205 1213 1205 1213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 1279 1281 1279 1281 <sup xmlns:xlink="http://www.w3.org/1999/xlink">54</sup>
###xml 1284 1286 1284 1286 <sup xmlns:xlink="http://www.w3.org/1999/xlink">52</sup>
###xml 1496 1497 1496 1497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf575f3">3</xref>
###xml 1569 1571 1569 1571 <sup xmlns:xlink="http://www.w3.org/1999/xlink">56</sup>
###xml 1641 1643 1641 1643 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 1649 1651 1649 1651 <sup xmlns:xlink="http://www.w3.org/1999/xlink">54</sup>
###xml 1697 1698 1697 1698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf575f2">2</xref>
###xml 1772 1774 1772 1774 <sup xmlns:xlink="http://www.w3.org/1999/xlink">56</sup>
###xml 1776 1778 1776 1778 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 1901 1903 1901 1903 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 1935 1943 1935 1943 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 1983 1985 1983 1985 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 1991 1993 1991 1993 <sup xmlns:xlink="http://www.w3.org/1999/xlink">54</sup>
###xml 2402 2409 2398 2405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 128 141 <span type="species:ncbi:5911">T.thermophila</span>
###xml 146 162 <span type="species:ncbi:5936">Euplotes crassus</span>
###xml 285 290 <span type="species:ncbi:9606">human</span>
###xml 328 333 <span type="species:ncbi:9606">human</span>
###xml 644 649 <span type="species:ncbi:9606">human</span>
###xml 839 844 <span type="species:ncbi:9606">human</span>
###xml 1081 1086 <span type="species:ncbi:9606">human</span>
###xml 1351 1356 <span type="species:ncbi:9606">human</span>
###xml 2208 2213 <span type="species:ncbi:9606">human</span>
Detailed functional analysis of the template residues in telomerase have previously been limited largely to ciliates, including T.thermophila and Euplotes crassus (53). This is the first study towards a detailed elucidation of the role of specific template residues in the function of human telomerase. Ideally, the recombinant human telomerase mutants described in this paper will be studied by a direct assay, for which there is no routine methodology yet established, owing to difficulties in expression and reconstitution. Consequently, we cannot absolutely rule out the possibility that substitution or deletion in the alignment domain of human telomerase may affect catalytic activity in ways that do not manifest under the conditions of our assays. There also exists the possibility that certain residues in the alignment domain of human telomerase may contribute to enzyme catalytic activity in other ways besides base pairing, such as the structure of the catalytic pocket. Our results do indicate that the integrity in both length and sequence of the alignment domain of human telomerase contributes to optimal overall activity, but with only a minor contribution from the first two 3' residues in vitro. On the basis of this study, we conclude that three residues (3'-54AUC52-5') are the minimum for efficient processive repeat addition by human telomerase. Our results are consistent with the level of sequence conservation in the alignment domain of vertebrate telomerase RNAs (Fig. 3B), with the least conserved (34%) residue of the 11 nt template region 56C not being essential. The next two residues in the alignment domain, 55A and 54A, respectively, are both 90% conserved (Fig. 2B). Interestingly, mutants with modification of the dinucleotide sequence 56CA55 show significant telomerase activity and high processivity, which supports the hypothesis that strongly conserved residue 55A is actually not essential for in vitro activity. However, replacement of both 55A and 54A abolished telomerase activity (Delta3 and Sub3), which is consistent with the conservation of both residues. Reasons for the presence of additional (>3) alignment domain residues of certain vertebrates, including human, are unclear. One possibility is that a more optimal structure in the RNA template for active site function results from the additional residues. Alternatively, there may exist an unknown in vivo function for these additional residues in certain organisms.
###end p 41
###begin title 42
Figures and Tables
###end title 42
###begin p 43
###xml 57 58 57 58 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 212 213 212 213 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 314 315 314 315 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 449 450 449 450 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 38 43 <span type="species:ncbi:9606">human</span>
 Telomeric DNA synthesis catalysed by human telomerase. (A) Telomerase catalytic protein (hTERT) is shown with the template sequence spanning nucleotides +46 to +56 of the RNA subunit (hTR) and the anchor site. (B) Primer annealing: the 3' end of the primer base pairs with the template region of telomerase RNA. (C) Primer extension by reverse transcription until the 5' end of the template is reached. Newly synthesised DNA is indicated in bold. (D) Translocation and re-alignment of the primer terminus to the 3' end of the template for a further round of extension. For non-natural substrates, primer annealing during first round synthesis is dictated by sequence complementarity between the primer 3' end and the template region. In subsequent rounds of synthesis, re-alignment of the primer 3' end is as described above (D).
###end p 43
###begin p 44
###xml 47 52 47 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 55 57 55 57 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf575c26">26</xref>
###xml 62 63 62 63 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 199 211 199 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Homo sapiens</italic>
###xml 226 239 226 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gallus gallus</italic>
###xml 256 273 256 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rattus norvegicus</italic>
###xml 289 301 289 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mus musculus</italic>
###xml 394 395 394 395 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 199 211 <span type="species:ncbi:9606">Homo sapiens</span>
###xml 213 218 <span type="species:ncbi:9606">human</span>
###xml 226 239 <span type="species:ncbi:9031">Gallus gallus</span>
###xml 241 248 <span type="species:ncbi:9031">chicken</span>
###xml 256 273 <span type="species:ncbi:10116">Rattus norvegicus</span>
###xml 275 278 <span type="species:ncbi:10116">rat</span>
###xml 289 301 <span type="species:ncbi:10090">Mus musculus</span>
###xml 303 308 <span type="species:ncbi:10090">mouse</span>
 Vertebrate telomerase RNAs [adapted from Chen et al. (26)]. (A) Alignment and consensus sequence of the template region of telomerase RNA from a variety of vertebrates. The sequences shown are from Homo sapiens (human, hTR), Gallus gallus (chicken, cTR), Rattus norvegicus (rat, rTR) and Mus musculus (mouse, mTR). The template sequence is shown in bold, the alignment domain in bold italic. (B) The consensus sequence. The level of sequence conservation in the template region of vertebrate telomerase RNAs is shown (compiled from 35 sequences of distantly related vertebrates).
###end p 44
###begin p 45
###xml 29 31 29 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink">56</sup>
###xml 33 35 33 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink">52</sup>
 Effect of deleting residues 56C-52C from the 3' end of the alignment domain on telomerase activity by TRAP assay. Lane 1, 1x CHAPS buffer; lane 2, TSR8 template amplification control; lane 3, wild-type telomerase from HeLa cell extracts; lane 4, RRL control (-hTR, -hTERT mRNA); lane 5, telomerase activity reconstituted from wild-type hTR; lanes 6-10, recombinant mutants Delta1, Delta2, Delta3, Delta4 and Delta5, respectively; lane 11, RRL control (+hTR, -hTERT mRNA); lane 12, RRL (-hTR, +hTERT mRNA). The internal PCR control band (I.C.) for the assay is indicated.
###end p 45
###begin p 46
###xml 2 3 2 3 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 504 505 496 497 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 558 559 550 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 559 560 551 552 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 665 666 657 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 666 667 658 659 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 34 39 <span type="species:ncbi:9606">human</span>
 (A) Activity and processivity of human telomerase mutants by a modified TRAP assay. Lane 1, 1x CHAPS control; lane 2, RRL without hTR; lane 3, recombinant telomerase activity reconstituted from wild-type hTR; lanes 4-13, recombinant telomerase activity reconstituted from variant telomerase RNAs, Delta1-Delta5 and Sub1-Sub5. For the standard assay conditions see Materials and Methods. The product bands selected for quantitative processivity analysis (Materials and Methods) are indicated by arrows. (B) Processivity of wild-type and mutants telomerases. P1 represents the processivity of wild-type and mutated telomerases at the first visible telomeric repeat; P2 is the processivity at the second repeat and so forth. See Materials and Methods for a description of quantitation and calculations performed. Reactions were performed in duplicate and the average processivity and standard deviation for each position were determined and plotted alongside the wild-type values.
###end p 46
###begin p 47
###xml 29 31 29 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink">56</sup>
###xml 33 35 33 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink">52</sup>
 Effect of deleting residues 56C-52C from the 3' end of the alignment domain on telomerase activity by TRAP assay using the alternative primer TS-GGG. Lane 1, telomerase activity reconstituted with wild-type hTR (wt hTR); lanes 2-6, recombinant mutants Delta1, Delta2, Delta3, Delta4 and Delta5, respectively. The percentage of telomerase activity reconstituted in each reaction is indicated relative to wild-type hTR under the respective lanes. The internal PCR control band (I.C.) for the assay is indicated.
###end p 47
###begin p 48
###xml 37 39 37 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink">56</sup>
###xml 41 43 41 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink">52</sup>
 Effect of substitutions of residues 56C-52C on telomerase activity as assayed by TRAP. Lane 1, 1x CHAPS buffer; lane 2, TSR8 template amplification; lane 3, wild-type telomerase from HeLa cell extracts; lane 4, RRL (-hTR, -hTERT mRNA); lane 5, telomerase activity reconstituted from wild-type hTR (wt hTR); lanes 6-10, Sub1, Sub2, Sub3, Sub4 and Sub5, respectively; lane 11, RRL (+hTR, -hTERT mRNA); lane 12, -hTR, +hTERT mRNA. The internal control (I. C.) for the assay is indicated.
###end p 48
###begin p 49
###xml 24 29 <span type="species:ncbi:9606">human</span>
###xml 547 552 <span type="species:ncbi:9606">human</span>
 Specific inhibition of human telomerase activity by competitor RNAs Delta4 and Delta5. Standard competition assays (see Materials and Methods) were performed with increasing amounts of the indicated competitor RNA. Lane 1, RRL control (-hTR, -hTERT mRNA); lane 2, wild-type hTR incubated without competitor RNA (wt hTR); lanes 3-6, wild-type hTR incubated with increasing amounts (1-, 10-, 20- and 50-fold molar excess) of mutant RNA Delta5, 1- and 20-fold molar excess of variant Delta4 (lanes 9 and 10) and 20-fold molar excess of non-specific human tRNA (lane 11); lane 7, Delta5 mutant added alone (0.1 microg/microl lysate); lane 8, as lane 5 but wild-type hTR (0.005 microg/microl lysate) was incubated without competitor RNA. The competitor and wild-type hTR were added simultaneously to the lysate before synthesis of hTERT. The percentage of telomerase activity reconstituted in each reaction is indicated under the respective lanes. The internal control (I.C.) for the TRAP assay is indicated.
###end p 49
###begin title 50
###xml 48 53 <span type="species:ncbi:9606">human</span>
Nomenclature, modifications and activity of the human telomerase RNA mutants
###end title 50
###begin p 51
Delta, deletion; Sub, substitution. The sequence of the alignment domain is written 3'-->5'. The values for activity are background corrected with respect to the RRL control (which showed 3 +/- 1% activity) and normalised with respect to the wild-type (taken as 100%). The values for activity represent the mean of at least three independent experiments.
###end p 51
###begin title 52
ACKNOWLEDGEMENTS
###end title 52
###begin p 53
We thank Dr Robert Weinberg for plasmid pCl-Neo-hTERT. We also thank Dr Wjatschesslaw Wlassoff and Andrew Whitney for helpful discussions. This work was funded by a grant from the BBSRC and the Cambridge European Trust.
###end p 53
###begin title 54
REFERENCES
###end title 54

